Market Tracker

01/16 1:05pm ET

Celldex Therapeutics Inc (NASDAQ:CLDX)

3.64
Delayed Data
As of Jan 13
 +0.02 / +0.55%
Today’s Change
2.85
Today|||52-Week Range
12.41
+2.82%
Year-to-Date
Why Celldex Therapeutics Imploded in 2016
Jan 09 / MotleyFool.com - Paid Partner Content
Celldex Therapeutics, Inc.'s 3 Best Moves in 2016
Jan 05 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close3.62
Today’s open3.61
Day’s range3.61 - 3.75
Volume1,522,890
Average volume (3 months)2,272,161
Market cap$368.5M
Dividend yield--
Data as of 4:00pm ET, 01/13/2017

Growth & Valuation

Earnings growth (last year)+0.76%
Earnings growth (this year)+1.34%
Earnings growth (next 5 years)--
Revenue growth (last year)+52.82%
P/E ratioNM
Price/Sales277.69
Price/Book1.24

Competitors

 Today’s
change
Today’s
% change
LNTHLantheus Holdings In...+0.15+1.69%
OXFDOxford Immunotec Glo...-0.14-0.98%
IMMUImmunomedics Inc+0.11+2.80%
VCYTVeracyte Inc+0.18+2.39%
Data as of 4:00pm ET, 01/13/2017

Financials

Next reporting dateMarch 9, 2017
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$5.5M
Annual profit (last year)-$127.2M
Net profit margin-2,321.11%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Anthony S. Marucci
CFO, Secretary, Treasurer &
Senior Vice President
Avery W. Catlin
Corporate headquarters
Hampton, New Jersey

Forecasts